Neuroblastoma
Primary Site | Histology | Behavior |
---|---|---|
C000-C699, C739-C750, C754-C809 | 9490, 9500 | 3 |
C700-C729, C751-C753 | 9490, 9500 | <Any value> |
Notes
9490, 9500: C000-C809 (all ages) **Note 1:** The following sources were used in the development of this schema * Toronto Childhood Cancer Stage Guidelines, Version 2, May 2022 https://cancerqld.blob.core.windows.net/content/docs/childhood-cancer-staging-for-population-registries.pdfData Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No |
NAACCR #390
dateOfDiagnosis |
None | None |
Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
All | None |
Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
All | None |
Behavior | <BLANK> | Yes |
NAACCR #523
behaviorCodeIcdO3 |
All | None |
International Neuroblastoma Risk Group Staging System | <BLANK> | No |
NAACCR #9611
intlNeuroblastomaRiskGrpStgSys |
SEER | SSDI |
n-MYC Amplification | <BLANK> | No |
NAACCR #9614
nMycAcmplification |
SEER | SSDI |
International Neuroblastoma Pathology Classification (INPC) | <BLANK> | No |
NAACCR #9610
inpc |
SEER | SSDI |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Toronto ID | 4a | NAACCR IDs are not final |
NAACCR #9617
torontoId |
None |
Toronto Version Number | 1 | NAACCR IDs are not final |
NAACCR #9620
torontoVersionNumber |
None |
Derived Version | {{ctx_alg_version}} | None | None | |
Derived Toronto T | 88 | NAACCR IDs are not final |
NAACCR #9607
derivedTorontoT |
None |
Derived Toronto N | 88 | NAACCR IDs are not final |
NAACCR #9605
derivedTorontoN |
None |
Derived Toronto M | 88 | NAACCR IDs are not final |
NAACCR #9604
derivedTorontoM |
None |
Derived Toronto Stage Group | 88 | NAACCR IDs are not final |
NAACCR #9606
derivedTorontoStageGroup |
None |